Congenital Hyperinsulinism research hub
3 indexed studies · 0 currently recruiting
- active not recruitingPHASE3
RZ358 Treatment for Congenital Hyperinsulinism
This study is testing a new medicine, RZ358, for children and adults with congenital hyperinsulinism (CHI). This condition causes very low blood sugar. The study will see how well RZ358 works to control blood sugar and if it's safe, compared to current treatments alone.
United States · Bulgaria · Denmark - active not recruitingPHASE2
HM15136 (Efpegerglucagon) Treatment for 8 Weeks in Subjects Aged ≥2 Years With Congenital Hyperinsulinism (CHI)
This study looks at a new medicine called HM15136 for children and adults (aged 2 and over) with congenital hyperinsulinism (CHI). It aims to see if the medicine is safe, well-tolerated, and helps reduce low blood sugar when added to existing treatments.
United States · Germany · Israel - active not recruitingPHASE3
Extension Trial Evaluating the Long-term Safety and Efficacy of Dasiglucagon in Children With Congenital Hyperinsulinism
This study looks at the long-term safety and effects of a treatment called dasiglucagon for children with a condition called congenital hyperinsulinism (CHI). It's for children who have already been in similar studies and helps doctors understand if the treatment is safe and works well over time.
United States · Germany · Israel